Deletion of the ABL SH3 domain reactivates de-oligomerized BCR-ABL for growth factor independence
Open Access
- 5 February 1996
- journal article
- Published by Wiley in FEBS Letters
- Vol. 379 (3) , 244-246
- https://doi.org/10.1016/0014-5793(95)01518-3
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Signalling through SH2 and SH3 domainsPublished by Elsevier ,2002
- Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogeneCell, 1995
- Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene.The Journal of Experimental Medicine, 1995
- Membrane targeting of the nucleotide exchange factor Sos is sufficient for activating the Ras signaling pathwayCell, 1994
- Differential Complementation of Bcr-Abl Point Mutants with c-MycScience, 1994
- The COOH terminus of the c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity [published erratum appears in J Cell Biol 1994 Mar;124(5):865]The Journal of cell biology, 1994
- SH3 domains direct cellular localization of signaling moleculesCell, 1993
- SH2 and SH3 domains: From structure to functionCell, 1992
- Dominant negative MYC blocks transformation by ABL oncogenesCell, 1992
- The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localizationCell, 1989